Recently I sat down with newly appointed Memphasys Director of Business Development Dr David Ali to talk about his global experience across research/ clinical trials, product development/ new product launches and sales, the important skills he brings to the Memphasys team, what attracted him to the company and importantly why he is excited about the future of the company and its product portfolio.
As always DYOR.
Q&A interview with Director of Business Development Dr David Ali
Add MEM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.06M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.8¢ | 0.8¢ | $2.975K | 371.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 1129310 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 500000 | 1 |
View Market Depth
| Last trade - 11.14am 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
0.8¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 0.8¢ | 0.8¢ | 0.8¢ | 196950 | ||
| Last updated 11.14am 06/06/2024 ? | |||||
| MEM (ASX) Chart |